Marianne Catharina Svanborg

This profile gathers the share dealings of Marianne Catharina Svanborg in Selectimmune Pharma AB. We count 3 filings; the first trade dates from 14 June 2019 and the latest from 9 December 2020.

On the market, this insider has only ever bought: 2 purchases, €295k in total. Unlike grants, an open-market purchase is paid for by the insider, at the market price. 2020 to date brings 1 purchase and no sales.

On 13 December 2020 came the latest disclosure, an open-market purchase for €3,952 in Selectimmune Pharma AB. Half of the filings or more reach the Finansinspektionen feed on the day of the trade. Under the Market Abuse Regulation, managers have three business days to notify their trades. This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.